2025 Pharmaceutical Manufacturing Vaccines 
Express Pharma
FEBRUARY 20, 2025
CDMO Live is set to take place on 7-8 May 2025 at Rotterdam’s World Trade Center, bringing together key decision-makers in pharmaceutical outsourcing. The demand for outsourcing in pharmaceutical manufacturing has grown significantly, with nine out of ten biotechnology companies now depending on contract partners for production.
Express Pharma
JANUARY 26, 2025
The Pharmaceutical Export Promotion Council of India (PHARMEXCIL) announces its renewed commitment to strengthening the strategic partnership between India and the United Arab Emirates (UAE) in the pharmaceutical sector.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 28, 2023
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
Quality Matters
APRIL 19, 2024
Given this dependence on foreign manufacturers, the African Union made regional production a central pillar of its New Public Health Order, and partnerships that support African-produced medicines, vaccines, and other medical products, are central to their efforts. But PEPFAR is looking to change how it does business.
Quality Matters
SEPTEMBER 10, 2024
We prioritize check-ins with stakeholders such as the Association of Medical Doctors and the Association of Pharmaceutical Manufacturers and Distributors regarding any issues with production. Looking ahead, APEC 2025 will be hosted in Korea. What are your team’s plans for that event?
European Pharmaceutical Review
FEBRUARY 20, 2025
3 Additionally, tariffs could increase lead times for manufacturing, as companies navigate customs barriers and seek alternative suppliers. For complex treatments such as biologics and vaccines, which require highly specialised production facilities, shifting supply chains is neither simple nor immediate. Available from: [link] 2.
Safe Biologics
MARCH 10, 2025
However, the nominee has also received criticism about his views on other health policies such as vaccine safety. Kennedy has insisted that he is not “anti-vaccine” and has pledged not to ban vaccines under Trump. PBM Reform: Could 2025 Finally See a Long-Awaited Overhaul? Read the FTC Report here.
Expert insights. Personalized for you.
101 
Let's personalize your content